2 Growth Stocks With Incredible Potential in the Next 5 Years
While there aren't any shortcuts to experiencing excellent returns on investment, the axiom "good things come to those who wait" isn't necessarily true when investing in biotech stocks. Specifically, there are no guarantees that positive early results will lead to positive later-stage clinical trials results, despite yearslong efforts put in to develop these drugs and therapies. More often than not, pharma and biotech investors can only gauge the chances of a company's success by weighing the results of its clinical trials against its available cash runway.
However, if that doesn't scare you off, and you're willing to take the risk and wait patiently, there's a pair of biotech stocks you should know, because of their massive potential to commercialize much-needed therapies and make shareholders richer. Let's dive in and see what makes them worth considering.
Image source: Getty Images.
Source Fool.com
